• Modus


'Brexit' is creating an uncertain time for all industries especially those which rely so heavily on relations with the EU – however regardless of the outcome, Parallel Imports of pharmaceuticals will continue.

The UK submitted the notification of its intention to withdraw from the European Union pursuant to Article 50 of the Treaty on European Union on 29 March 2017.

Until the UK leaves the EU or Article 50 is extended or revoked, the UK remains a full member of the EU and all the rights and obligations of EU membership remain in force.

If the UK leaves the EU without a deal (“no-deal”), regulation of medicines, medical devices and clinical trials will be affected. 

Further information on 'Brexit' can be found here.

#brexit #eu #uk #article50 #nodeal

5 views0 comments

Recent Posts

See All